Skip to main content

Outcomes in Patients with Obstructive Jaundice from Metastatic Colorectal Cancer and Implications for Management



Patients with metastatic colorectal cancer can develop jaundice from intrahepatic or extrahepatic causes. Currently, there is little data on the underlying causes and overall survival after onset of jaundice. The purpose of this study was to characterize the causes of jaundice and determine outcomes.


Six hundred twenty-nine patients treated for metastatic colorectal cancer between 2004 and 2010 were retrospectively reviewed. Those developing jaundice were grouped as having intrahepatic or extrahepatic obstruction. Demographics, clinicopathologic, and outcome data were analyzed.


Sixty-two patients with metastatic colorectal cancer developed jaundice. Intrahepatic biliary obstruction was most common, occurring in younger patients. Time from metastatic diagnosis to presentation of jaundice was similar between groups, as was the mean number of prior lines of chemotherapy. Biliary decompression was successful 41.7 % of the time and was attempted more commonly for extrahepatic causes. Median overall survival after onset of jaundice was 1.5 months and it was similar between groups, but improved to 9.6 months in patients who were able to receive further chemotherapy.


Jaundice due to metastatic colorectal cancer is an ominous finding, representing aggressive tumor biology or exhaustion of therapies. Biliary decompression is often difficult and should only be pursued when additional treatment options are available.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–259.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Leporrier J, Maurel J, Chiche L, et al. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006;93(4):465–474.

    Article  CAS  PubMed  Google Scholar 

  3. Lam VW, Spiro C, Laurence JM, et al. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases. Ann Surg Oncol 2012; 19(4):1292–1301.

    Article  PubMed  Google Scholar 

  4. Abdalla EK, Bauer TW, Chun YS, et al. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB(Oxford) 2013;15(2):119–130.

  5. Warshaw AL and Welch JP. Extrahepatic biliary obstruction by metastatic colon carcinoma. Ann Surg 1978;188(5):593–597.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Douillard JY, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol 2010;28(31):4697–4705.

    Article  CAS  PubMed  Google Scholar 

  7. Tveit KM, Guren T, Glimelius B, et al. Phase III trial of cetuximab with continous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J Clin Oncol 2012;30(15):1755–1762.

    Article  CAS  PubMed  Google Scholar 

  8. Van Laethem JL, De Broux S, Eisendrath P, et al. Clinical Impact of biliary drainage and jaundice resolution in patients with obstructive jaundice at the hilum. Am J Gastroenterol 2003;98(6):1271–1277.

    Article  PubMed  Google Scholar 

  9. Lo CY and Lai EC. Palliation for extrahepatic biliary obstruction by metastatic colorectal carcinoma. Am J Gastroenterol 1994;89(10):1852–1855.

    CAS  PubMed  Google Scholar 

  10. Elias DM and Ouellet JF. Incidence, distribution, and significance of hilar node metastases in hepatic colorectal metastases. Surg Oncol Clin N Am 2003;12(1):221–229.

    Article  PubMed  Google Scholar 

  11. Bennett JJ, Schmidt CR, Klimstra DS, et al. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Ann Surg Oncol 2008;15(4):1130–1136.

    Article  PubMed  Google Scholar 

  12. Rodgers MS, and McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: a systemic review. Br J Surg 2000;87(9):1142–1155.

    Article  CAS  PubMed  Google Scholar 

  13. Laurent C, Sa Cunha A, Rullier E, et al. Smith Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastases. J Am Coll Surg 2004;198(6):884–891.

    Article  PubMed  Google Scholar 

  14. Beckurts KT, Holscher AH, Thorban S, et al. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 1997;(8):1081–1084.

    Article  Google Scholar 

  15. Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic Resection for Metastatic Colorectal Adenocarcinoma: A Proposal of a Prognostic Scoring System. J Am Coll Surg 1999;189(3):291–299.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Caprizo DR, Are C, Jarnagin W, Dematteo R, Fong Y, Gonen M, Blumgart L, D’Angelica M. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Onc. 2009;16(8):2138–2146.

    Article  Google Scholar 

  17. Nakamura S, Suzuki S, and Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years’ experience. J Hepatobiliary Pancreat Surg 1999;6(1):16–22.

    Article  CAS  PubMed  Google Scholar 

  18. Ercolani G, Grazi GL, Ravaioli M, et al. The role of lymphadenectomy for liver tumors. Ann Surg. 2004;239(2):202–209.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Jamison RL Donohue JH Nagorney DM et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132(5):505–510.

    Article  CAS  PubMed  Google Scholar 

  20. Elias D, Ouellet JF, Bellon N, et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003;90(5):567–574.

    Article  CAS  PubMed  Google Scholar 

Download references


No grant or funding was used during this study.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Mark Bloomston.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nichols, S.D., Albert, S., Shirley, L. et al. Outcomes in Patients with Obstructive Jaundice from Metastatic Colorectal Cancer and Implications for Management. J Gastrointest Surg 18, 2186–2191 (2014).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Metastatic colorectal cancer
  • Hepatic metastasis
  • Biliary obstruction
  • Jaundice
  • Hyperbilirubinemia